Novartis Investigative Site

Sakarya 54290

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria, Non-small Cell Lung Cancer

Studies at this site

• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines — Completed
• This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC. — Stopped early